Concepedia

Author

Stephan Spahn

University of TübingenORCID

Also Known As

S Spahn, S. Spahn, Spahn, Stephan, Stephan Spahn

56

Publications

1.7K

Citations

9

H-Index

13

Concepts

All Affiliations

University of TübingenHeidelberg UniversityMedical University of ViennaGerman Cancer Research CenterUniversity Hospital of Bern
SS

About

Stephan Spahn is an author at University of Tübingen specializing in immunology, molecular signaling, and gene expression.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

42

2

Natural Sciences

1

1

42

3

Cell Biology

1

1

42

4

Cellular Physiology

1

1

42

5

Immunology

1

1

42

Stephan Spahn

×

8

Publications

1.7K

Citations

8

H-Index

YearCitations

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol,

Nature

2021

1.2K

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score

Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein,

Journal of Hepatology

2021

284

Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular Carcinoma

Stephan Spahn, Daniel Roessler, Radu Pompilia,

Cancers

2020

70

Generation and functional characterization of epithelial cells with stable expression of SLC26A9 Cl<sup>−</sup> channels

Johanna J. Salomon, Stephan Spahn, Xiaohui Wang,

American Journal of Physiology-Lung Cellular and Molecular Physiology

2016

42

Prenatal diagnosis of multicystic dysplastic kidney disease in the second trimester screening

Ammar Al Naimi, Jan‐Eric Baumüller, Stephan Spahn,

Prenatal Diagnosis

2013

39

Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma

Michael Bitzer, Stephan Spahn, Sepideh Babaei,

npj Precision Oncology

2021

28

Natriuretic peptide levels in intrauterine growth-restricted fetuses with absent and reversed end-diastolic flow of the umbilical artery in relation to ductus venosus flow velocities

Franz Bahlmann, Frank Krummenauer, Stephan Spahn,

Journal of Perinatal Medicine

2011

21

The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma

Stephan Spahn, Fabian Kleinhenz, Ekaterina Shevchenko,

Nature Communications

2024

18

Page 1